Global Pharma Clinical Trial Digitization Market

Pharma Clinical Trial Digitization Comprehensive Study by Application (Pharmaceutical Companies, Biotechnology Companies, Academic and Government Research Institutes, Others), Trial Types (Digital Continuity across Clinical Trial IT Systems, Patient-Centric Remote And Virtual Trial Design, Direct-To-Patient Home Services), End-Use (Clinical Data Management, Trial Monitoring, Patient Recruitment and Enrollment), Service Type (Drug Dose Adjustment, Drug Impact Monitoring, Medical Prescription System, Bioprinting, Preventive Therapy, Individualized Drug Printing) Players and Region - Global Market Outlook to 2028

Pharma Clinical Trial Digitization Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Pharma Clinical Trial Digitization Market Overview:
Medical care has improved dramatically in the past few decades and has led to a better quality of life for patients and their families. However, biopharmaceutical companies admit that progress is still being made in clinical trials, particularly the high cost of research and development (R&D), the risk of failure, and the reliability of data due to archaic practices. It appears that the current way of conducting clinical trials is coming to an end. As the world moves into a more digitized age, clinical trials are driven by the introduction of new technologies that are rapidly accelerating the digital transformation of their processes. Many of the new technologies are aimed at increasing operational efficiency and are used in activities such as patient recruitment, improving compliance, data collection and analysis, and decision-making through IA and big data. By 2020, digitization will fuel a third of growth and an estimated 40 percent of the profitability in the pharmaceutical market. In order to be able to make optimal use of digitalization, all clinical research organizations, biotech, or pharmaceutical companies must optimize their own infrastructure so that new technologies can have an impact. Adapting to a digital mindset in a clinical setting is a new business imperative. To continue to rapidly develop new and emerging therapies, biotech companies must incorporate new technologies and develop a comprehensive digital R&D strategy.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Adoption of Platform-as-a-Service (PaaS) and Mobile Computing and The Growth in Number of Clinical Trials by Market Players

Market Growth Drivers:
Growing Demand for Quality Data, Increasing Adoption of New Technology in Clinical Research and Increasing Diseases Prevalence

Challenges:
Presence and Availability of Global Brands

Restraints:
Cost of Raw Materials and Impact of Domestic Tariffs and Trade Routes

Opportunities:
Growing Demand for Personalized Medicine Is Expected To Create New Opportunity for the Pharma Clinical Trial Digitization and Growing Research & Development Promoting Outsourcing

Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Antidote Technologies, Inc. (United States), ActiGraph LLC (United States), Aparito Ltd. (United Kingdom), Clinerion Ltd. (Switzerland), CliniOps, Inc. (United States), Science 37 (United States), Evidation Health (United States), ConsilX (Singapore), Deep 6 AI (United States), Koneksa Health Inc. (United States), 4G Clinical (United States), Medidata Solutions (United States), Oracle Corporation (United States), THREAD Research (United States), PatientsLikeMe (United States) and Trialbee (Sweden). Additionally, following companies can also be profiled that are part of our coverage like TriNetX, Inc. (United States) and Veeva Systems (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Pharma Clinical Trial Digitization market by 2028. Considering Market by Trial Types, the sub-segment i.e. Digital Continuity across Clinical Trial IT Systems will boost the Pharma Clinical Trial Digitization market. Considering Market by End-Use, the sub-segment i.e. Clinical Data Management will boost the Pharma Clinical Trial Digitization market. Considering Market by Service Type, the sub-segment i.e. Drug Dose Adjustment will boost the Pharma Clinical Trial Digitization market.

What Can be Explored with the Pharma Clinical Trial Digitization Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Pharma Clinical Trial Digitization Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Pharma Clinical Trial Digitization
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pharma Clinical Trial Digitization market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Pharma Clinical Trial Digitization market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Pharma Clinical Trial Digitization, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Application
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Government Research Institutes
  • Others
By Trial Types
  • Digital Continuity across Clinical Trial IT Systems
  • Patient-Centric Remote And Virtual Trial Design
  • Direct-To-Patient Home Services

By End-Use
  • Clinical Data Management
  • Trial Monitoring
  • Patient Recruitment and Enrollment

By Service Type
  • Drug Dose Adjustment
  • Drug Impact Monitoring
  • Medical Prescription System
  • Bioprinting
  • Preventive Therapy
  • Individualized Drug Printing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Quality Data
      • 3.2.2. Increasing Adoption of New Technology in Clinical Research
      • 3.2.3. Increasing Diseases Prevalence
    • 3.3. Market Challenges
      • 3.3.1. Presence and Availability of Global Brands
    • 3.4. Market Trends
      • 3.4.1. Adoption of Platform-as-a-Service (PaaS) and Mobile Computing
      • 3.4.2. The Growth in Number of Clinical Trials by Market Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharma Clinical Trial Digitization, by Application, Trial Types, End-Use, Service Type and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharma Clinical Trial Digitization (Value)
      • 5.2.1. Global Pharma Clinical Trial Digitization by: Application (Value)
        • 5.2.1.1. Pharmaceutical Companies
        • 5.2.1.2. Biotechnology Companies
        • 5.2.1.3. Academic and Government Research Institutes
        • 5.2.1.4. Others
      • 5.2.2. Global Pharma Clinical Trial Digitization by: Trial Types (Value)
        • 5.2.2.1. Digital Continuity across Clinical Trial IT Systems
        • 5.2.2.2. Patient-Centric Remote And Virtual Trial Design
        • 5.2.2.3. Direct-To-Patient Home Services
      • 5.2.3. Global Pharma Clinical Trial Digitization by: End-Use (Value)
        • 5.2.3.1. Clinical Data Management
        • 5.2.3.2. Trial Monitoring
        • 5.2.3.3. Patient Recruitment and Enrollment
      • 5.2.4. Global Pharma Clinical Trial Digitization by: Service Type (Value)
        • 5.2.4.1. Drug Dose Adjustment
        • 5.2.4.2. Drug Impact Monitoring
        • 5.2.4.3. Medical Prescription System
        • 5.2.4.4. Bioprinting
        • 5.2.4.5. Preventive Therapy
        • 5.2.4.6. Individualized Drug Printing
      • 5.2.5. Global Pharma Clinical Trial Digitization Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Pharma Clinical Trial Digitization (Price)
  • 6. Pharma Clinical Trial Digitization: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Antidote Technologies, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ActiGraph LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aparito Ltd. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Clinerion Ltd. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CliniOps, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Science 37 (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Evidation Health (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ConsilX (Singapore)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Deep 6 AI (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Koneksa Health Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. 4G Clinical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Medidata Solutions (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Oracle Corporation (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. THREAD Research (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. PatientsLikeMe (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Trialbee (Sweden)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Pharma Clinical Trial Digitization Sale, by Application, Trial Types, End-Use, Service Type and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharma Clinical Trial Digitization (Value)
      • 7.2.1. Global Pharma Clinical Trial Digitization by: Application (Value)
        • 7.2.1.1. Pharmaceutical Companies
        • 7.2.1.2. Biotechnology Companies
        • 7.2.1.3. Academic and Government Research Institutes
        • 7.2.1.4. Others
      • 7.2.2. Global Pharma Clinical Trial Digitization by: Trial Types (Value)
        • 7.2.2.1. Digital Continuity across Clinical Trial IT Systems
        • 7.2.2.2. Patient-Centric Remote And Virtual Trial Design
        • 7.2.2.3. Direct-To-Patient Home Services
      • 7.2.3. Global Pharma Clinical Trial Digitization by: End-Use (Value)
        • 7.2.3.1. Clinical Data Management
        • 7.2.3.2. Trial Monitoring
        • 7.2.3.3. Patient Recruitment and Enrollment
      • 7.2.4. Global Pharma Clinical Trial Digitization by: Service Type (Value)
        • 7.2.4.1. Drug Dose Adjustment
        • 7.2.4.2. Drug Impact Monitoring
        • 7.2.4.3. Medical Prescription System
        • 7.2.4.4. Bioprinting
        • 7.2.4.5. Preventive Therapy
        • 7.2.4.6. Individualized Drug Printing
      • 7.2.5. Global Pharma Clinical Trial Digitization Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Pharma Clinical Trial Digitization (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharma Clinical Trial Digitization: by Application(USD Million)
  • Table 2. Pharma Clinical Trial Digitization Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 3. Pharma Clinical Trial Digitization Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 4. Pharma Clinical Trial Digitization Academic and Government Research Institutes , by Region USD Million (2017-2022)
  • Table 5. Pharma Clinical Trial Digitization Others , by Region USD Million (2017-2022)
  • Table 6. Pharma Clinical Trial Digitization: by Trial Types(USD Million)
  • Table 7. Pharma Clinical Trial Digitization Digital Continuity across Clinical Trial IT Systems , by Region USD Million (2017-2022)
  • Table 8. Pharma Clinical Trial Digitization Patient-Centric Remote And Virtual Trial Design , by Region USD Million (2017-2022)
  • Table 9. Pharma Clinical Trial Digitization Direct-To-Patient Home Services , by Region USD Million (2017-2022)
  • Table 10. Pharma Clinical Trial Digitization: by End-Use(USD Million)
  • Table 11. Pharma Clinical Trial Digitization Clinical Data Management , by Region USD Million (2017-2022)
  • Table 12. Pharma Clinical Trial Digitization Trial Monitoring , by Region USD Million (2017-2022)
  • Table 13. Pharma Clinical Trial Digitization Patient Recruitment and Enrollment , by Region USD Million (2017-2022)
  • Table 14. Pharma Clinical Trial Digitization: by Service Type(USD Million)
  • Table 15. Pharma Clinical Trial Digitization Drug Dose Adjustment , by Region USD Million (2017-2022)
  • Table 16. Pharma Clinical Trial Digitization Drug Impact Monitoring , by Region USD Million (2017-2022)
  • Table 17. Pharma Clinical Trial Digitization Medical Prescription System , by Region USD Million (2017-2022)
  • Table 18. Pharma Clinical Trial Digitization Bioprinting , by Region USD Million (2017-2022)
  • Table 19. Pharma Clinical Trial Digitization Preventive Therapy , by Region USD Million (2017-2022)
  • Table 20. Pharma Clinical Trial Digitization Individualized Drug Printing , by Region USD Million (2017-2022)
  • Table 21. South America Pharma Clinical Trial Digitization, by Country USD Million (2017-2022)
  • Table 22. South America Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 23. South America Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 24. South America Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 25. South America Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 26. Brazil Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 27. Brazil Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 28. Brazil Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 29. Brazil Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 30. Argentina Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 31. Argentina Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 32. Argentina Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 33. Argentina Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 34. Rest of South America Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 35. Rest of South America Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 36. Rest of South America Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 37. Rest of South America Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 38. Asia Pacific Pharma Clinical Trial Digitization, by Country USD Million (2017-2022)
  • Table 39. Asia Pacific Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 40. Asia Pacific Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 41. Asia Pacific Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 42. Asia Pacific Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 43. China Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 44. China Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 45. China Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 46. China Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 47. Japan Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 48. Japan Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 49. Japan Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 50. Japan Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 51. India Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 52. India Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 53. India Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 54. India Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 55. South Korea Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 56. South Korea Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 57. South Korea Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 58. South Korea Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 59. Taiwan Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 60. Taiwan Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 61. Taiwan Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 62. Taiwan Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 63. Australia Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 64. Australia Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 65. Australia Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 66. Australia Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 71. Europe Pharma Clinical Trial Digitization, by Country USD Million (2017-2022)
  • Table 72. Europe Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 73. Europe Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 74. Europe Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 75. Europe Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 76. Germany Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 77. Germany Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 78. Germany Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 79. Germany Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 80. France Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 81. France Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 82. France Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 83. France Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 84. Italy Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 85. Italy Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 86. Italy Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 87. Italy Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 88. United Kingdom Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 89. United Kingdom Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 90. United Kingdom Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 91. United Kingdom Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 92. Netherlands Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 93. Netherlands Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 94. Netherlands Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 95. Netherlands Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 96. Rest of Europe Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 97. Rest of Europe Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 98. Rest of Europe Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 99. Rest of Europe Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 100. MEA Pharma Clinical Trial Digitization, by Country USD Million (2017-2022)
  • Table 101. MEA Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 102. MEA Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 103. MEA Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 104. MEA Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 105. Middle East Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 106. Middle East Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 107. Middle East Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 108. Middle East Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 109. Africa Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 110. Africa Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 111. Africa Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 112. Africa Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 113. North America Pharma Clinical Trial Digitization, by Country USD Million (2017-2022)
  • Table 114. North America Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 115. North America Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 116. North America Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 117. North America Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 118. United States Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 119. United States Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 120. United States Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 121. United States Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 122. Canada Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 123. Canada Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 124. Canada Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 125. Canada Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 126. Mexico Pharma Clinical Trial Digitization, by Application USD Million (2017-2022)
  • Table 127. Mexico Pharma Clinical Trial Digitization, by Trial Types USD Million (2017-2022)
  • Table 128. Mexico Pharma Clinical Trial Digitization, by End-Use USD Million (2017-2022)
  • Table 129. Mexico Pharma Clinical Trial Digitization, by Service Type USD Million (2017-2022)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Pharma Clinical Trial Digitization: by Application(USD Million)
  • Table 147. Pharma Clinical Trial Digitization Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 148. Pharma Clinical Trial Digitization Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 149. Pharma Clinical Trial Digitization Academic and Government Research Institutes , by Region USD Million (2023-2028)
  • Table 150. Pharma Clinical Trial Digitization Others , by Region USD Million (2023-2028)
  • Table 151. Pharma Clinical Trial Digitization: by Trial Types(USD Million)
  • Table 152. Pharma Clinical Trial Digitization Digital Continuity across Clinical Trial IT Systems , by Region USD Million (2023-2028)
  • Table 153. Pharma Clinical Trial Digitization Patient-Centric Remote And Virtual Trial Design , by Region USD Million (2023-2028)
  • Table 154. Pharma Clinical Trial Digitization Direct-To-Patient Home Services , by Region USD Million (2023-2028)
  • Table 155. Pharma Clinical Trial Digitization: by End-Use(USD Million)
  • Table 156. Pharma Clinical Trial Digitization Clinical Data Management , by Region USD Million (2023-2028)
  • Table 157. Pharma Clinical Trial Digitization Trial Monitoring , by Region USD Million (2023-2028)
  • Table 158. Pharma Clinical Trial Digitization Patient Recruitment and Enrollment , by Region USD Million (2023-2028)
  • Table 159. Pharma Clinical Trial Digitization: by Service Type(USD Million)
  • Table 160. Pharma Clinical Trial Digitization Drug Dose Adjustment , by Region USD Million (2023-2028)
  • Table 161. Pharma Clinical Trial Digitization Drug Impact Monitoring , by Region USD Million (2023-2028)
  • Table 162. Pharma Clinical Trial Digitization Medical Prescription System , by Region USD Million (2023-2028)
  • Table 163. Pharma Clinical Trial Digitization Bioprinting , by Region USD Million (2023-2028)
  • Table 164. Pharma Clinical Trial Digitization Preventive Therapy , by Region USD Million (2023-2028)
  • Table 165. Pharma Clinical Trial Digitization Individualized Drug Printing , by Region USD Million (2023-2028)
  • Table 166. South America Pharma Clinical Trial Digitization, by Country USD Million (2023-2028)
  • Table 167. South America Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 168. South America Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 169. South America Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 170. South America Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 171. Brazil Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 172. Brazil Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 173. Brazil Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 174. Brazil Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 175. Argentina Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 176. Argentina Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 177. Argentina Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 178. Argentina Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 179. Rest of South America Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 180. Rest of South America Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 181. Rest of South America Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 182. Rest of South America Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 183. Asia Pacific Pharma Clinical Trial Digitization, by Country USD Million (2023-2028)
  • Table 184. Asia Pacific Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 185. Asia Pacific Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 186. Asia Pacific Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 187. Asia Pacific Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 188. China Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 189. China Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 190. China Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 191. China Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 192. Japan Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 193. Japan Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 194. Japan Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 195. Japan Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 196. India Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 197. India Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 198. India Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 199. India Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 200. South Korea Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 201. South Korea Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 202. South Korea Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 203. South Korea Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 204. Taiwan Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 205. Taiwan Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 206. Taiwan Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 207. Taiwan Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 208. Australia Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 209. Australia Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 210. Australia Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 211. Australia Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 212. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 213. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 214. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 215. Rest of Asia-Pacific Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 216. Europe Pharma Clinical Trial Digitization, by Country USD Million (2023-2028)
  • Table 217. Europe Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 218. Europe Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 219. Europe Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 220. Europe Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 221. Germany Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 222. Germany Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 223. Germany Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 224. Germany Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 225. France Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 226. France Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 227. France Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 228. France Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 229. Italy Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 230. Italy Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 231. Italy Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 232. Italy Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 233. United Kingdom Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 234. United Kingdom Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 235. United Kingdom Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 236. United Kingdom Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 237. Netherlands Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 238. Netherlands Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 239. Netherlands Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 240. Netherlands Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 241. Rest of Europe Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 242. Rest of Europe Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 243. Rest of Europe Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 244. Rest of Europe Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 245. MEA Pharma Clinical Trial Digitization, by Country USD Million (2023-2028)
  • Table 246. MEA Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 247. MEA Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 248. MEA Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 249. MEA Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 250. Middle East Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 251. Middle East Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 252. Middle East Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 253. Middle East Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 254. Africa Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 255. Africa Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 256. Africa Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 257. Africa Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 258. North America Pharma Clinical Trial Digitization, by Country USD Million (2023-2028)
  • Table 259. North America Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 260. North America Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 261. North America Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 262. North America Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 263. United States Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 264. United States Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 265. United States Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 266. United States Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 267. Canada Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 268. Canada Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 269. Canada Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 270. Canada Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 271. Mexico Pharma Clinical Trial Digitization, by Application USD Million (2023-2028)
  • Table 272. Mexico Pharma Clinical Trial Digitization, by Trial Types USD Million (2023-2028)
  • Table 273. Mexico Pharma Clinical Trial Digitization, by End-Use USD Million (2023-2028)
  • Table 274. Mexico Pharma Clinical Trial Digitization, by Service Type USD Million (2023-2028)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharma Clinical Trial Digitization: by Application USD Million (2017-2022)
  • Figure 5. Global Pharma Clinical Trial Digitization: by Trial Types USD Million (2017-2022)
  • Figure 6. Global Pharma Clinical Trial Digitization: by End-Use USD Million (2017-2022)
  • Figure 7. Global Pharma Clinical Trial Digitization: by Service Type USD Million (2017-2022)
  • Figure 8. South America Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 9. Asia Pacific Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 10. Europe Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 11. MEA Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 12. North America Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 13. Global Pharma Clinical Trial Digitization share by Players 2022 (%)
  • Figure 14. Global Pharma Clinical Trial Digitization share by Players (Top 3) 2022(%)
  • Figure 15. Global Pharma Clinical Trial Digitization share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Antidote Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Antidote Technologies, Inc. (United States) Revenue: by Geography 2022
  • Figure 19. ActiGraph LLC (United States) Revenue, Net Income and Gross profit
  • Figure 20. ActiGraph LLC (United States) Revenue: by Geography 2022
  • Figure 21. Aparito Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Aparito Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 23. Clinerion Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Clinerion Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 25. CliniOps, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. CliniOps, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Science 37 (United States) Revenue, Net Income and Gross profit
  • Figure 28. Science 37 (United States) Revenue: by Geography 2022
  • Figure 29. Evidation Health (United States) Revenue, Net Income and Gross profit
  • Figure 30. Evidation Health (United States) Revenue: by Geography 2022
  • Figure 31. ConsilX (Singapore) Revenue, Net Income and Gross profit
  • Figure 32. ConsilX (Singapore) Revenue: by Geography 2022
  • Figure 33. Deep 6 AI (United States) Revenue, Net Income and Gross profit
  • Figure 34. Deep 6 AI (United States) Revenue: by Geography 2022
  • Figure 35. Koneksa Health Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Koneksa Health Inc. (United States) Revenue: by Geography 2022
  • Figure 37. 4G Clinical (United States) Revenue, Net Income and Gross profit
  • Figure 38. 4G Clinical (United States) Revenue: by Geography 2022
  • Figure 39. Medidata Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 40. Medidata Solutions (United States) Revenue: by Geography 2022
  • Figure 41. Oracle Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Oracle Corporation (United States) Revenue: by Geography 2022
  • Figure 43. THREAD Research (United States) Revenue, Net Income and Gross profit
  • Figure 44. THREAD Research (United States) Revenue: by Geography 2022
  • Figure 45. PatientsLikeMe (United States) Revenue, Net Income and Gross profit
  • Figure 46. PatientsLikeMe (United States) Revenue: by Geography 2022
  • Figure 47. Trialbee (Sweden) Revenue, Net Income and Gross profit
  • Figure 48. Trialbee (Sweden) Revenue: by Geography 2022
  • Figure 49. Global Pharma Clinical Trial Digitization: by Application USD Million (2023-2028)
  • Figure 50. Global Pharma Clinical Trial Digitization: by Trial Types USD Million (2023-2028)
  • Figure 51. Global Pharma Clinical Trial Digitization: by End-Use USD Million (2023-2028)
  • Figure 52. Global Pharma Clinical Trial Digitization: by Service Type USD Million (2023-2028)
  • Figure 53. South America Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 54. Asia Pacific Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 55. Europe Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 56. MEA Pharma Clinical Trial Digitization Share (%), by Country
  • Figure 57. North America Pharma Clinical Trial Digitization Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Antidote Technologies, Inc. (United States)
  • ActiGraph LLC (United States)
  • Aparito Ltd. (United Kingdom)
  • Clinerion Ltd. (Switzerland)
  • CliniOps, Inc. (United States)
  • Science 37 (United States)
  • Evidation Health (United States)
  • ConsilX (Singapore)
  • Deep 6 AI (United States)
  • Koneksa Health Inc. (United States)
  • 4G Clinical (United States)
  • Medidata Solutions (United States)
  • Oracle Corporation (United States)
  • THREAD Research (United States)
  • PatientsLikeMe (United States)
  • Trialbee (Sweden)
Additional players considered in the study are as follows:
TriNetX, Inc. (United States) , Veeva Systems (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 234 Pages 54 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharma Clinical Trial Digitization Market Quantitative research analysis
Global Pharma Clinical Trial Digitization Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Pharma Clinical Trial Digitization market are Antidote Technologies, Inc. (United States), ActiGraph LLC (United States), Aparito Ltd. (United Kingdom), Clinerion Ltd. (Switzerland), CliniOps, Inc. (United States), Science 37 (United States), Evidation Health (United States), ConsilX (Singapore), Deep 6 AI (United States), Koneksa Health Inc. (United States), 4G Clinical (United States), Medidata Solutions (United States), Oracle Corporation (United States), THREAD Research (United States), PatientsLikeMe (United States) and Trialbee (Sweden), to name a few.
"Adoption of Platform-as-a-Service (PaaS) and Mobile Computing " is seen as one of major influencing trends for Pharma Clinical Trial Digitization Market during projected period 2022-2028.

Know More About Global Pharma Clinical Trial Digitization Market Report?

Have a Query? Click Here

Other Related Reports

Brain Computer Interface Technology Comprehensive Study by Type (Invasive BCI, Non Invasive BCI), Components (Signal Acquisition, Feature Extraction, Feature Translation, Device Output), Industry Ver...
$ 3650
Total Lab Automation Comprehensive Study by Application (Drug Discovery, Clinical Diagnostics, Proteomics Solutions, Genomics), Software Type (Laboratory Information Management System (LIMS), Laborat...
$ 3750
Digital Transformation in Healthcare Comprehensive Study by Organization Size (Large Enterprises, SMEs), Technology (Artificial Intelligence (AI), Cloud Computing, Big data and Analytics, Internet of...
$ 3750
Covid-19 Impact on Telemedicine Technologies and Services Comprehensive Study by Application (Dermatology, Gynecology, Neurology, Cardiology, Orthopedics, Others), Solutions (Hardware (Telemedicine K...
$ 3750
Artificial Intelligence in Drug Discovery Comprehensive Study by Application (Disease Identification/Diagnosis, Digital Therapeutics / Personalized Treatment/Behavioral Modification, Drug Discovery a...
$ 3750
Clinical Urine Testing Comprehensive Study by Type (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, PoC Analyzers), Application (UTI, Diabetes, Pregnancy, Others), End-users (Hospitals,...
$ 3450